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Single molecule characterization of the interactions between amyloid-β
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and the membranes of hippocampal cells
Abstract
Oligomers of the 40 and 42 residue amyloid-β peptides (Aβ40 and Aβ42) have been implicated in the
neuronal damage and impaired cognitive function associated with Alzheimer’s disease. However, little is
known about the specific mechanisms by which these misfolded species induce such detrimental effects
on cells. In this work, we use single-molecule imaging techniques to examine the initial interactions
between Aβ monomers and oligomers and the membranes of live cells. This highly sensitive method
enables the visualization of individual Aβ species on the cell surface and characterization of their
oligomerization state, all at biologically relevant, nanomolar concentrations. The results indicate that
oligomers preferentially interact with cell membranes, relative to monomers and that the oligomers
become immobilized on the cell surface. Additionally, we observe that the interaction of Aβ species with
the cell membrane is inhibited by the presence of ATP-independent molecular chaperones. This study
demonstrates the power of this methodology for characterizing the interactions between protein
aggregates and the membranes of live neuronal cells at physiologically relevant concentrations and
opens the door to quantitative studies of the cellular responses to potentially pathogenic oligomers.
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ABSTRACT: Oligomers of the 40 and 42 residue amyloid-β peptides (Aβ40 and Aβ42) have been
implicated in the neuronal damage and impaired cognitive function associated with Alzheimer’s
disease. However, little is known about the speciﬁc mechanisms by which these misfolded species
induce such detrimental eﬀects on cells. In this work, we use single-molecule imaging techniques to
examine the initial interactions between Aβ monomers and oligomers and the membranes of live
cells. This highly sensitive method enables the visualization of individual Aβ species on the cell
surface and characterization of their oligomerization state, all at biologically relevant, nanomolar
concentrations. The results indicate that oligomers preferentially interact with cell membranes,
relative to monomers and that the oligomers become immobilized on the cell surface. Additionally,
we observe that the interaction of Aβ species with the cell membrane is inhibited by the presence of
ATP-independent molecular chaperones. This study demonstrates the power of this methodology
for characterizing the interactions between protein aggregates and the membranes of live neuronal
cells at physiologically relevant concentrations and opens the door to quantitative studies of the
cellular responses to potentially pathogenic oligomers.

■

the application of total internal reﬂection ﬂuorescence
microscopy (TIRFM) enables us to study the cell-surface
interactions resulting from the exogenous application of wellcharacterized Aβ assemblies and to investigate their diﬀusional
behavior on the cell surfaces. Employing the same methodology,
we have also been able to examine the eﬀects of molecular
chaperones on the interaction of Aβ species with cell membranes.
TIRFM enables the observation of species at the cell
membrane speciﬁcally as ﬂuorescent signals are collected only
at the interface of the coverslip and the sample placed upon it; if a
cell is present in this illuminated region, any ﬂuorescent species
attached to the cell membrane will be detected. Moreover, these
experiments can be performed at concentrations as low as 1 nM,
enabling investigations to be carried out at near-endogenous Aβ
concentrations (1−10 nM).17 In this work, we have performed a
detailed biophysical characterization of the interactions between
oligomers of the 40 and 42 residue isoforms of Aβ (Aβ40 and
Aβ42 respectively) and the membranes of live neuronal cells in
order to enable comparisons to be made between the eﬀects of
the two peptides. As the hippocampus is the part of the brain

INTRODUCTION
Proteinaceous deposits, primarily comprised of plaques of
amyloid-β peptides (Aβ), are a pathological hallmark of
Alzheimer’s disease (AD) and are present in the brains of
patients at the later stages of AD. Recent research has suggested,
however, that soluble oligomers of Aβ are the primary origin of
neuronal damage and decline in cognitive function associated
with the disease.1−10 Of the numerous suggested mechanisms of
Aβ-mediated neurotoxicity, many include interactions with a
variety of cellular components and, in particular, with cell
membranes.11−16 Therefore, in order to understand the
detrimental eﬀects of Aβ aggregates, it is crucial to characterize
the earliest events in the pathogenic process, namely the
interactions between Aβ and cellular membranes.
One of the primary challenges in resolving the detailed
mechanism of Aβ-mediated neurotoxicity is the heterogeneous
nature of the Aβ species formed during the aggregation reaction.
Conventional biochemical techniques provide information about
the overall behavior of the ensemble of species present in a given
sample, from which it is challenging to deﬁne the roles of speciﬁc
components within the ensemble. In this study, therefore, we
have used single-molecule imaging to visualize individual Aβ
species and to diﬀerentiate between monomers and the various
types of oligomers observed in these experiments. Speciﬁcally,
© 2013 American Chemical Society
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Figure 1. Schematic diagram of the single-molecule methods used to detect species in solution (top) and those interacting with cell membranes
(bottom). Black panels are two-color ﬂuorescence images and blue panels show spot detection in red circles. All scale bars are 5 μm.

most notably aﬀected in AD, an immortalized murine hippocampal neuronal cell line (HpL) was chosen for these studies.18
To generate oligomers of the Aβ peptides which could be
observed by TIRFM, equimolar quantities of monomeric Aβ
(labeled with either a HiLyteFluor488 or a HiLyteFluor647
ﬂuorophore) were combined and allowed to aggregate for a
period of time which previous work has shown to generate
oligomers.19 Earlier studies have also conﬁrmed that the
attachment of these ﬂuorescent tags at the N-terminus of the
peptide does not signiﬁcantly aﬀect the aggregation properties of
the Aβ peptides.19−21 Within the aggregation mixture, the
oligomers can be distinguished from monomers by selecting for
species containing two diﬀerently colored ﬂuorophores, whereas
monomers are tagged with only a single ﬂuorophore, either
HiLyteFluor488 or HiLyteFluor647. Thus, when the oligomer
mixtures were observed using two-color TIRFM, it is
straightforward not only to count the number of Aβ species
present but also to characterize each of these species as a
monomer or an oligomer by analyzing the spatial coincidence of
the ﬂuorescent signals of diﬀerent colors (see Supporting
Information and Figures 1 and S1). Additionally, we could gain
an added dimension of detail by using the ﬂuorescence intensity
of the dual-color oligomers to estimate their size20,21 (see
Supporting Information and Figure S2). We have performed this
characterization for Aβ species present in the aggregation
mixtures as well as for those which interact with cell membranes
after incubating the Aβ mixtures with neuronal cells (Figure 1).
Since TIRFM is highly sensitive to nonspeciﬁc binding of
molecules to the surface under observation, it was important to
develop a robust protocol which enabled us to observe cellspeciﬁc Aβ interactions while minimizing the nonspeciﬁc
adhesion of Aβ species to the coverslip (Figure 2).

■

Figure 2. Representative images of HpL cells incubated with (A) and
without (B) 500 nM of ﬂuorescently labeled Aβ42 that has undergone
aggregation for 3−4 h. In each pair of images, the left is the phase
contrast image, and the right is the ﬂuorescent (TIRFM) image. Yellow
species in the ﬂuorescent image are oligomers (dually labeled), whereas
green and red species are monomers (singly labeled). Scale bars are 3
μm. (C) Aβ40 and Aβ42 monomeric and oligomeric species were
detectable over the limits of nonspeciﬁc interaction with the slide surface
and over the background ﬂuorescence of unlabeled cells 500 nM total
peptide concentration, number of cells varied from 35 to 50 for each
category, error bars are standard error of the mean, (SEM).

EXPERIMENTAL SECTION

Cell Culture. Murine hippocampal HPL (P4, Prnp−/−) cells were
cultured in Opti-MEM media (GIBCO) supplemented with 10% fetal
bovine serum (Sigma St. Louis, MO) and 1% penicillin/streptomycin
(GIBCO, Carlsbad, CA) in a 5% CO2 environment at 37 °C.18 These
cells do not express the prion protein receptor (PrPC), which, recently,
has been suggested to mediate the cellular toxicity of Aβ peptides. We
used this cell line to examine the basal levels of Aβ binding to a model
surface in the absence of the inﬂuence of this putative receptor.
Aβ Peptide Preparation. Monomeric solutions of HiLyteFluor488
and HiLyteFluor647-labeled Aβ40 or Aβ42 (Anaspec, San Jose, CA)
were prepared by dissolving the lyophilized peptide in 0.01 M NaOH
followed by sonication over ice for 30 min (Bandelin Sonorex, Schalltec

Morfelden-Walldorf, Germany) and subsequent ﬂash freezing into
aliquots.22 Prior to each of the incubations, aliquots of each peptide were
brought to pH 7.4 by diluting into SSPE buﬀer (150 mM NaCl, 10 mM
NaH2PO4, 10 mM Na2EDTA, pH 7.4) to the desired concentration and
placed under the chosen conditions for aggregation (37 °C, agitation, 1
1492
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and 2 μM of Aβ42 and Aβ40, respectively, for time dependence
measurements and 10 and 20 μM of Aβ42 and Aβ40, respectively, for
concentration dependence experiments). The concentration of each
labeled peptide was measured before mixing using confocal two-colorcoincidence detection (cTCCD).19 The peptides were aggregated for
3−4 h at lower concentrations (1 or 2 μM) for time dependence
measurements and aggregated for 1 h at higher concentrations (10 or 20
μM) for concentration dependence experiments.
TIRFM Instrumentation. Imaging was performed using TIRFM by
aligning the outputs from a HeNe laser operating at 633 nm
(25LHP991230, Melles Griot, Albuquerque, NM) and a diode laser
operating at 488 nm (PC13589, Spectra Physics, Santa Clara, CA) and
directing them down the edge of a TIRF objective (60× Plan Apo TIRF,
NA 1.45, Nikon Instruments, New York, NY) mounted on a Nikon
Eclipse TE2000-U microscope. Fluorescence collected by the same
objective was separated from the returning TIR beam by a dichroic
(FF500/646-Di1, Semrock, Rochester, NY), split into blue and red
components (585 DXLR, Omega Optical, Brattleboro, VT) and ﬁltered
using Dual-View (Optical Insights, Lilburn, CA) mounted ﬁlters. The
images were simultaneously recorded on an EMCCD camera (Cascade
II: 512, Photometrics, Tuscon, AZ) operating at −70 °C, whereby the
emission signal from the 488 and 647 nm ﬂuorophores was split so that
each color was recorded on one-half of the EMCCD chip (Dual-View,
Photometrics, Roper Scientiﬁcs, Tuscon, AZ) with a pixel size of 106
nm. Data were acquired at 28.6 frames s−1 using Micromanager.23 To
achieve good image registration, a grid consisting of regularly spaced
ion-beam etched holes in gold-on-glass was utilized. The Dual-View
optics were adjusted so as to maximize the overlap of the images of the
grid in the two channels under white-light illumination, resulting in a
measured mean image registration of approximately 100 nm.
Characterization of Aβ in Solution. Solutions containing labeled
Aβ monomers and/or oligomers (prepared as described above) were
diluted to a total peptide concentration of 1 nM in PBS (see Figure 1)
and spin coated onto glass coverslips (2000 rpm, 1 min, model WS400B-6NPP/Lite, Laurell Tech., North Wales, PA) for imaging. The
intensity of the excitation laser(s) was adjusted so that single
ﬂuorophores (monomers) could be eﬃciently discriminated against
the background. The microscope coverslips had been incubated for 1 h
in piranha solution (3:1 sulfuric acid:hydrogen peroxide), thoroughly
rinsed with ultrapure water (Milli-Q, 18.2 MΩ resistance), and
subsequently cleaned with oxygen plasma for 2 min (Femto, Electronic
Diener, Royal Oak, MI).
Characterization of Aβ on Cells. At least 24 h prior to
experiments, cells were seeded in six-well plates (Delta plates,
NUNC). For the experiments, cells were incubated with sterile PBS
(12 min, 37 °C) after which they could be easily removed from the
surface by aspirating with a pipet. Cells were resuspended in DMEM/
10% FCS or Opti-MEM/10% FCS and incubated in an Eppendorf tube
for 15 min at 37 °C with the ﬂuorophore-labelled Aβ solutions
containing monomers and/or oligomers, at the concentrations
described in the text. For experiments with chaperones, the Aβ40
samples were preincubated with equimolar amounts of αB-crystallin or
clusterin for at least 15 min at room temperature. Then these mixtures
were added to the cell suspensions. Following incubation, the cells were
washed twice with the culture media and once with PBS by
centrifugation and resuspension of the pellet (600 × g, 2 min). Prior
to imaging, coverslips were cleaned as described above and subsequently
coated with a 1 mg/mL solution of PLL(20)-g[3.7]-PEG(2.3)/
PEG(3.4)-RGD(12%) (PLL-PEG-RGD) (SuSoS, AG, Switzerland)
for 10 min at room temperature.24−26 Any unbound PLL-PEG-RGD
was then thoroughly washed oﬀ using PBS. This coating allowed the
cells to bind to the functionalized surface via their integrin receptors, and
the polyethyleneglycol reduced the nonspeciﬁc Aβ adherence to the
coverslip by a factor of 50. With this protocol we were able to ensure that
the only Aβ species observed were those bound to the cells under
observation. Slides were transferred to the microscope stage, and the
cells were added, allowed to settle for 5 min, and then imaged within the
subsequent 20 min at room temperature. Due to the washing steps
involved in the sample preparation, we could not ensure that these
measurements were taken at equilibrium. Therefore, we have chosen to

make comparisons between values of the measured parameters rather
than analyzing the absolute values.
Preparation of Chaperones. Human recombinant αB-crystallin
was prepared as described previously.27 Clusterin was extracted from
human serum from Wollongong Hospital (Wollongong, NSW,
Australia), as described previously.28
Particle Detection. Images were analyzed using custom-written
software (MATLAB). With this software, the user interactively selects
boundaries for each cell based on white light images acquired during the
data collection phase. The corresponding ﬂuorescence images were then
band-pass ﬁltered, and a threshold for the subsequent spot detection was
determined from the background. First, a distribution of values of the
median background ﬂuorescence was determined, and spots were
identiﬁed as species having a brightness value greater than the sum of the
median background ﬂuorescence and twice the interquartile range of the
background. This threshold was empirically determined with a number
of test samples including monomeric Aβ on glass coverslips and cells.
Detection of spots corresponding to Aβ oligomers was performed using
ﬁrst a centroid and subsequently a Gaussian ﬁt to bright objects with
spot intensities corrected for the local background then extracted. Large
oligomers were distinguished from closely associated monomers by
deﬁning a maximum allowed ellipticity for a detected particle. A few cells
were observed to have ﬁbrillar species bound to them (Figure S3). These
were discarded from the analysis as they represented a small fraction of
the total population of cells and because oligomers have been identiﬁed
as the key toxic species.10
Particle Tracking and Diﬀusion Analysis. The positions of each
particle in each frame were recorded, and the spots were tracked using
custom-written MATLAB code which linked the spot positions from
frame to frame by an implementation of the IDL particle tracking
function deﬁned by Crocker and Grier.29 The trajectories were then
analyzed using two approaches, a mean-square displacement (MSD)
analysis and a jump−distance (JD) analysis.
For the MSD analysis, the MSDs over the ﬁrst ﬁve time intervals were
calculated, and individual diﬀusion coeﬃcients obtained, using the linear
relationship between MSD and a given time interval between frames
dt.30 Brieﬂy, for each recorded trajectory (points {x(i), y(i)}), MSD
values were calculated using the method described by Qian et al. and
Saxton and Jacobsen.31,32 They deﬁne the MSD for a given time lag ndt
as the average over all points with that time lag:
MSD(ndt ) =

1
l−n

l−n

∑ [x(i + n) − x(i)]2

+ [y(i + n) − y(i)]2

i=1

(1)
with l denoting the trajectory length and dt the time step between
frames. It holds that

MSD(ndt ) = 4Dndt + offset

(2)

with D denoting the short-term diﬀusion coeﬃcient; the gradient of a
linear ﬁt for n ≤ 5 is therefore proportional to D. A weighted ﬁt was used
as errors are assumed to be approximately normally distributed.
For the JD analysis, the distances between particle positions in
subsequent frames, the so-called jump distances, were calculated, and
compiled into histograms. These histograms reﬂect the probability
distribution of the distance that a particle moves in the set time between
frames, and this distribution can be ﬁtted with a linear combination of
the two-dimensional diﬀusion equation to extract diﬀusion coeﬃcients
of multiple diﬀusing populations30,33,34.
m

p(r ) =

∑
j=1

Mf j
2Djdt

e −r

2

/4Djdt

rdr
(3)

The MSD analysis of the trajectories was additionally used to obtain an
estimate for the diﬀusion coeﬃcients of individual oligomers in order to
correlate diﬀusion and oligomer brightness.
Size Determination. Since almost all of the oligomers were found
to be static, their positions and intensities were averaged over multiple
frames before bleaching occurred. Coincident spots were detected by
calculating the distance between the spots in the blue and red
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channels.35 Here we required associated particles to stay within 300 nm
of each other to account for imperfections in image registration (Figure
S1). First, the mean brightness of a red monomer Imon was estimated by
analyzing bleaching traces manually using ImageJ (NIH, freeware,
Figure S2). Then the ﬂuorescence intensity collected from the 633 nm
excitation channel I633 for each coincident spot detected was doubled
and then scaled by the monomer brightness determined by photobleaching, and the size of the spot was expressed in terms of numbers of
monomers. This method assumes that no quenching takes place in
higher oligomers, which has been found to be a good approximation up
to ca 20-mers.21
size =

I633 × 2
Imon

(4)

The size distribution was then corrected for the undetected (single
color) fraction of oligomers (e.g., single-color dimers, trimers, etc.) from
the binomial probabilities of detection. The correction factor (F) for a
given oligomer size n, as given below, is less than 1% for oligomers over
7-mers in size:
n

Fn =

∑0 Cxn
1 − (C0n + Cnn)

(5)

× Nn)] was
Then the total number of oligomeric spots
determined following this correction. This was taken as a fraction of the
total number of species detected Ntotal for all plots where quantities are
expressed as fractions:
[∑50
0 (Fn

Figure 3. (A) Representative TIRFM images with arrows depicting the
increased fraction of Aβ oligomers on the surfaces of hippocampal cells.
The oligomeric fraction of Aβ42 and Aβ40 (B) on cell membranes and
in solution prior to incubation with cells (aggregation concentrations
used were 1 μM Aβ42 and 2 μM Aβ40); Aβ species were analyzed at
diﬀerent times during the aggregation reaction. For characterization of
species prior to incubation with cells, the data were derived from three
separate incubations. The oligomeric fraction of Aβ interacting with cell
membranes as a function of diﬀerent incubation concentrations of Aβ42
(C) and Aβ40 (D) (ANOVA single factor p = 0.17 for Aβ40 and p = 0.65
for Aβ42); distribution of sizes of oligomers after 4 h of aggregation of
Aβ42 (E) or Aβ40 (F) present in solution (prior to incubation with
cells) and on cell membranes (aggregation concentrations used were 1
μM Aβ42 and 2 μM Aβ40, n = 30−50 cells). All error bars are SEM; * is
p < 0.05; ** is p < 0.01; n.s. p > 0.05.

50

Ntotal = (N633 + N488) −

∑ (Fn × Nn)
0

(6)

Further statistical analysis was performed using Origin (OriginLab).

■

RESULTS
Oligomers of Aβ40 and Aβ42 Preferentially Interact
with the Cell Membrane Relative to Aβ Monomers. With
the conﬁdence that only speciﬁc interactions between the Aβ
peptides and the cell membranes are observed by this technique
(Figure 2), we examined whether the distribution of species of
Aβ present in solution was diﬀerent from the distribution of Aβ
species interacting with cell membranes. To this end, we
incubated the cells with solutions of Aβ (both Aβ40 and Aβ42)
that had been allowed to aggregate for various periods of time
and concurrently characterized the solution in the absence of
cells by spin-coating the solution onto a glass coverslip and
imaging both samples using dual-excitation TIRFM. Previous
studies have conﬁrmed that characterization of oligomer
formation by this method accurately describes the species
found in solution.19
We then quantiﬁed the number and sizes of Aβ species in
solution before and after incubation with cells. We accomplished
this objective by using TIRFM ﬁrst to characterize a solution of
Aβ species containing both oligomers and monomers. Then this
same solution was added to a suspension of cells, incubated with
the cells for at least 15 min, and then the cells were separated
from the soluble medium via centrifugation. The cells were then
visualized using TIRFM, and the species on the cell surface were
characterized as monomers or oligomers. Both monomers and
oligomers were observed to interact with the surfaces of the cells.
We then compared the oligomeric fraction of the Aβ40 or Aβ42
(number of oligomers relative to the total species) present in
solution with the fraction of the oligomeric Aβ40 or Aβ42 species
interacting with the cell membrane. This analysis revealed that
the fraction of Aβ40 or Aβ42 oligomers interacting with the cell
membrane was 5−7-fold greater than their fraction observed in
solution (Figure 3, A,B, paired two-tailed t test, p < 0.01).

Since the numbers of oligomeric species and their size
distributions are dependent on the progress of the aggregation
reaction, we next examined whether or not the enrichment of
oligomers at the cell surface changed with the time that Aβ40 and
Aβ42 were left to aggregate in the absence of cells. We found that
the increase in oligomeric fraction of Aβ at the cell surfaces
(compared to that in solution) was similar for Aβ40 and Aβ42
having undergone aggregation for times ranging from 2 to 12 h.
The oligomeric fractions of Aβ40 and Aβ42 present on cell
membranes were not found to be signiﬁcantly diﬀerent from each
other (p = 0.33, two sample independent t test). We were
interested in whether the concentration of Aβ (40 or 42) in the
incubation mixture with the cells aﬀects the oligomeric fraction of
Aβ interacting with the cell membrane. Varying the concentration of Aβ40 or Aβ42 (taken at a ﬁxed time during the
aggregation) in the solution in which the cells were incubated did
not signiﬁcantly change the oligomeric fraction of either isoform
interacting with the cells (Figure 3C,D, ANOVA, single factor, p
= 0.83, Figure S5). For both Aβ40 and Aβ42, the size distribution
of the oligomeric species that were associated with cell surfaces
was skewed toward larger species than those present in solution
(Figure 3E,F), a ﬁnding in accord with other work on Aβ40.20
The increased oligomeric fraction of Aβ (of both isoforms)
observed on the cell membrane, relative to the oligomeric
1494
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fraction of Aβ in solution, reﬂects a preferential adherence of
oligomers (over monomers) to the cell membrane. This
increased fraction is not due to further aggregation of Aβ in
solution during the incubation with the cells; we can exclude this
mechanism because the diﬀerence in the oligomeric fraction of
Aβ in solution and on cells is far greater than the diﬀerence in the
oligomeric fraction of Aβ observed in solution over the entire
aggregation reaction. Aβ oligomers possess a greater amount of
solvent-exposed hydrophobic surface area than monomers, a
property which may favor their interaction with cell membranes
and has also been correlated with their cellular toxicity.36
Mobility of Aβ40 and Aβ42 Oligomers is Inversely
Correlated with Oligomer Size. Having established that the
relative levels of oligomeric species are enriched at cell
membranes compared to the solution phase, we then
investigated the nature of the interaction with the membranes.
As our technique enables visualization of single-Aβ species and
characterization of their oligomer state, we examined whether or
not there were any diﬀerences in the mobility of oligomers and
monomers in the cell membrane. To accomplish this objective,
we acquired videos of the Aβ species on cell surfaces. Since
oligomers are likely to contain two diﬀerently colored
ﬂuorophores (HiLyteFluor488 and HiLyteFluor647), excitation
with a 488 nm laser will result in ﬂuorescence resonance energy
transfer (FRET) between the two ﬂuorophores and therefore a
ﬂuorescent signal from both detection channels. Therefore, we
acquired the videos using single-color excitation (488 nm) for
the TIRFM. Then, single-particle tracking algorithms were used
to link the images of these species in subsequent frames within
each video, thus obtaining trajectories of individual Aβ species in
the cell membrane (representative frames shown in Figure 4A,B
and video in Supporting Information).
First an analysis of the mean-square displacements (MSD) of
each trajectory was used to estimate the diﬀusion coeﬃcients of
each molecule (Figure 4C). The average ﬂuorescence intensity of
each molecule was extracted simultaneously with the estimation
of its diﬀusion coeﬃcient (see Experimental section). Since the
ﬂuorescence intensity of an Aβ species is correlated with its size,
the simultaneous estimation of intensity and diﬀusion coeﬃcient
allows us to investigate whether or not there is a relationship
between the size of an Aβ assembly and its mobility in the cell
membrane. Using the diﬀusion coeﬃcients obtained from the
MSD approach, we observed a clear negative correlation between
the diﬀusion rate of a single Aβ species and its size (as assessed by
its intensity). This observation holds for both Aβ40 and Aβ42
(Figure 4D). For Aβ40, we observe a subpopulation of small,
fast-diﬀusing species. We can identify these species as
monomeric since they do not undergo FRET and have low
ﬂuorescence intensities. If only the species that undergo FRET
(i.e., oligomers) of both Aβ40 and Aβ42 are examined, the small,
fast-diﬀusing population is not observed (Figure 4E). Interestingly the diﬀusion coeﬃcients of the oligomers are small, and
their trajectories indicate conﬁned motion32 (Figure 4A,B,E).
Mobility of Oligomers of Aβ40 and Aβ42 in the Cell
Membrane is Highly Restricted. Extracting diﬀusion
coeﬃcients using an MSD analysis can be challenging for
heterogeneous samples with multiple mobility populations and
short trajectory lengths. Therefore the diﬀusion coeﬃcients
obtained using the MSD approach should be considered as
approximate rather than exact values. In order to quantify the
diﬀusion of the Aβ species interacting with the cell, we employed
a second approach called JD analysis.30,33,34,37 For this analysis a
histogram of the displacement of a particle in a given time

Figure 4. (A,B) Representative frames taken from a live cell imaging
experiment to monitor Aβ40 diﬀusion in the cell membrane; the Aβ40
molecules were labeled with HiLyte488 and HiLyte647 ﬂuorophores.
(A) Monomers and oligomers (488 channel); (B) species undergoing
FRET (633 nm channel, Aβ oligomers). The trajectories obtained by
linking the images of the Aβ species in (A) and (B) are shown in (C).
From the ensemble plots, it is already apparent that, in contrast to the
small species present in (A), the motion of the large oligomers (deﬁned
as species that undergo FRET) is highly restricted. (D) A representative
plot of the MSDs as a function of time for a mobile Aβ40 species (yellow
arrows and trajectories in (C); the diﬀusion coeﬃcient obtained from
the ﬁt is D = 0.063 ± 0.020 μm2/s. (E) The diﬀusion coeﬃcient as
estimated by the MSD analysis as a function of species intensity (which
correlates with size) for both Aβ42 and Aβ40. Each point represents an
Aβ monomer or oligomer. (F) The estimated diﬀusion coeﬃcient as a
function of species intensity for only the oligomers of Aβ42 and Aβ40.
Concentrations used are 1 μM Aβ42 and 2 μM Aβ40.

interval (jump-distance) is created. This histogram corresponds
to the probability of a particle moving a certain distance in a given
time; we can therefore ﬁt this histogram with the two1495
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diﬀusing population (observed with the MSD approach) was
identiﬁed as one of three mobility populations with an ensemble
diﬀusion coeﬃcient of D4 = 0.225 ± 0.016 μm2/s.
We conﬁrmed that this conﬁnement was not an artifact of the
TIRFM method since very little interaction exists between the
oligomers and the coated coverslip, and species even larger than
the oligomers observed have been found to move using
TIRFM.38 One possible explanation for the restricted diﬀusion
of the majority of the oligomers of Aβ40 and Aβ42 is that the
oligomers are attached to the membrane or a membrane
component connected to the cytoskeletal framework of the cell.
However, further investigation is required to explore this
phenomenon in more detail.
Presence of ATP-Independent Chaperones Inhibits the
Interaction Between Aβ40 and Cell Membranes. Having
established a methodology for observing and characterizing the
interaction of Aβ with cell membranes, we examined the way in
which molecular chaperones can aﬀect this process. The
extracellular chaperone, clusterin, and the intracellular chaperone, αB-crystallin, act in an ATP-independent manner to inhibit
protein aggregation in vitro and to suppress the cytotoxicity of
amyloid-related oligomers.39,40 Previous studies using singlemolecule techniques have observed interactions between both of
these chaperones and the Aβ40 peptide.19,41 We therefore aimed
to investigate whether or not the presence of these chaperones
could modulate the interaction of Aβ40 with cell membranes.
Solutions containing Aβ40 oligomers were ﬁrst incubated with
stoichiometric amounts of either clusterin or αB-crystallin and
then added to the cells; we then quantiﬁed the number of
oligomers and monomers interacting with the cells.
When comparing the species interacting with the cell surfaces
in the presence and absence of the chaperones, it is apparent that
the presence of either chaperone reduced the interaction of all
Aβ40 species with cell membranes (Figure 6). This inhibition of
binding may be attributable to the sequestration of Aβ40 species
by these chaperones (as it has been previously observed in vitro)
or as a result of interactions of the chaperone molecules
themselves with the cell membrane. Further experiments will be
needed to distinguish these and other possibilities, but in any case
it is apparent that the presence of these chaperones reduces the
number of oligomers interacting with the cellular membranes.

dimensional diﬀusion equation (see Experimental section). In
this way, multiple diﬀusing populations can be resolved using a
linear combination of the two-dimensional diﬀusion equation
with varying diﬀusion coeﬃcients, D, representing the various
mobility populations, and amplitudes, A, representing the
relative abundance of these populations.
When we applied the JD analysis to our data, we found that a
minimum of three mobility populations was required to ﬁt the
experimentally derived JD distributions for both Aβ40 (D2, D3,
D4) and Aβ42 (D1, D2, D3) (adjusted R2 = 0.94 for two
populations compared to R2 = 0.98 for three populations). The
majority of the Aβ40 and Aβ42 species interacting with the cell
membrane were found to be either conﬁned (D1, D2 between
0.00053−0.004 μm2/s) or slow moving (D3 between 0.038−
0.050 μm2/s) (Figure 5, and Table 1). For Aβ40, the fast-

■

Figure 5. Distributions of particle displacements (JDs, blue histogram)
per unit time (35 ms) of monomers and oligomers of Aβ42 (A) and
Aβ40 (B) ﬁt to the two-dimensional diﬀusion equation for three
diﬀusing populations (eq 3, black line). The three components of the ﬁt
are shown in red, green, and cyan (A) and green, cyan, and purple (B),
respectively. Concentrations used are 1 μM Aβ42 and 2 μM Aβ40.

DISCUSSION
This work outlines a quantitative biophysical approach to
studying the early stages of the interaction of Aβ species with the
membranes of live cells. We have shown that oligomeric species
interact preferentially with cell surfaces relative to monomeric
peptides. The oligomeric fraction of Aβ42 interacting with the

Table 1. Diﬀusion Coeﬃcients (D) and Relative Abundances (A) for All Experimental Conditions Studied in This Work

monomers and
oligomers (Aβ42)
oligomers only
(Aβ42)
monomers and
oligomers (Aβ40)
oligomers only
(Aβ40)

D1 (conﬁneda)
[μm2/s]

A1[%]

D2 (conﬁneda)
[μm2/s]

A2 [%]

D3 (slow)
[μm2/s]

A2 [%]

D4 (fast)
[μm2/s]

A4 [%]

0.00053 ± 0.00001

21.2 ± 0.6

0.0040 ± 0.0002

32.5 ± 1.0

0.043 ± 0.001

46.3 ± 1.2

−

−

0.00052 ± 0.00002

20.7 ± 0.9

0.0034 ± 0.0002

34.8 ± 1.2

0.038 ± 0.001

44.5 ± 1.2

−

−

−

−

0.0045 ± 0.0004

12.6 ± 0.7

0.050 ± 0.002

60.7 ± 2.0

0.226 ± 0.016

26.7 ± 2.3

−

−

0.0045b

42.2 ± 1.5

0.0503b

57.8 ± 3.3

0.2256b

0.002 ± 0.025

Note that these populations are conﬁned within the localization precision of 34.4 ± 15.0 nm (see also Figure S1). bThe values for D1, D2, and D3
were ﬁxed in order to enable a comparison of the fraction of species with varying mobility across all species of Aβ40 and Aβ40 oligomers only. Errors
were calculated by bootstrapping using the size of the original data set and 1000 repetitions.
a
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proteins (10−2 and 10−1 μm2/s). This result suggests that the
majority of the Aβ species are not bound to a mobile cell-surface
protein and could be interacting with a more immobile partner,
for example, a cytoskeleton-associated membrane component.42,43 However, future investigations are needed to evaluate
the causes of restricted diﬀusion in detail. Larger oligomers
exhibit slower motion than smaller oligomers which could be a
consequence of diﬀerential levels of membrane integration due
to diﬀerent degrees of exposed hydrophobic surface area.36,44,45
Indeed, varying levels of exposed hydrophobic surface area have
been correlated with diﬀerent toxicity.36 Moreover, the
preincubation of oligomeric solutions of Aβ40 with either
clusterin or αB-crystallin prior to their addition to cells prevents
the interaction of the Aβ40 species with the cell surface.
This study illustrates a methodology with the potential to
examine in detail how various biologically relevant molecules
inﬂuence the interactions between the various Aβ species and cell
membranes. While numerous cellular studies of Aβ examine
eﬀects at concentrations that are 100- and 1000-fold higher than
those present physiologically, our use of single-molecule imaging
enables us to work at near physiological, nanomolar concentrations, which are particularily relevant to the initial stages of Aβinduced AD pathology.
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Characterization of localisation precision and monomer
intensity, Supporting Figures 1−5.
The video is representative of those taken during the data
acquisition process. HiLyte488 or 647 labeled Aβ interacts with
the plasma membrane of live hippocampal cells (data shown after
application of a band-pass ﬁlter). This material is available free of
charge via the Internet at http://pubs.acs.org.
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cell membrane is not signiﬁcantly diﬀerent from that of Aβ40,
suggesting that oligomers of both peptides have a similar aﬃnity
for cell membranes. On the cell surface most oligomers of both
isoforms display restricted motion, characterized by diﬀusion
coeﬃcients between 10−4 and 10−3 μm2/s, values that are far
lower than the diﬀusion coeﬃcients of mobile transmembrane
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